S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
OTCMKTS:MDCL

Medicine Man Technologies (MDCL) Stock Price, News & Analysis

$1.30
-0.04 (-2.99%)
(As of 02/26/2024 ET)
Today's Range
$1.15
$1.38
50-Day Range
$0.54
$1.45
52-Week Range
$1.05
$4.05
Volume
122,445 shs
Average Volume
84,948 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

MDCL stock logo

About Medicine Man Technologies Stock (OTCMKTS:MDCL)

Medicine Man Technologies, Inc. provides advisory and consulting services related to cannabis cultivation. It offers consulting, application and licensing, cultivation technology, dispensary operations, facility design and training services. The firm products include Nutrients, The Big Tomato and Three A Light. The company was founded by Andrew Williams on March 20, 2014 and is headquartered in Denver, CO.

MDCL Stock Price History

MDCL Stock News Headlines

Medicine Man Technologies Inc.
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
MDC Inducts 138 Qualified Doctors
See More Headlines
Receive MDCL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicine Man Technologies and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Business Services
Sub-Industry
Cannabis
Current Symbol
OTCMKTS:MDCL
Previous Symbol
NASDAQ:MDCL
Fax
N/A
Employees
25
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for March 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Justin Dye
    Executive Chairman & Chief Executive Officer
  • Nancy Bush Huber
    Chief Financial Officer
  • Nirup Krishnamurthy
    Chief Integration & Information Officer
  • Lee Alexander Dayton
    Chief Administrative Officer
  • Marc Harvill
    Manager-Business Development














MDCL Stock Analysis - Frequently Asked Questions

How have MDCL shares performed in 2024?

Medicine Man Technologies' stock was trading at $0.6097 at the beginning of 2024. Since then, MDCL shares have increased by 113.2% and is now trading at $1.30.
View the best growth stocks for 2024 here
.

What other stocks do shareholders of Medicine Man Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medicine Man Technologies investors own include Curaleaf (CURLF), Charlotte's Web (CWBHF), Trulieve Cannabis (TCNNF), KushCo (KSHB), Organigram (OGI), Green Thumb Industries (GTBIF), Innovative Industrial Properties (IIPR) and CV Sciences (CVSI).

How do I buy shares of Medicine Man Technologies?

Shares of MDCL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:MDCL) was last updated on 2/27/2024 by MarketBeat.com Staff